Gülden Yılmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gülden Yılmaz has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Cantürk Taşçı
Division of Pulmonology, Gulhane Faculty of Medicine & Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey
4 shared publications - Deniz Doğan
UNIVERSITY OF HEALTH SCIENCES, GÜLHANE SCHOOL OF MEDICINE, GÜLHANE MEDICINE PR. (ANKARA)
4 shared publications - Yakup Arslan
Department of Pulmonology Gülhane Education and Research Hospital, University of Health Sciences Ankara Türkiye
4 shared publications - Gonca Fidan
UNIVERSITY OF HEALTH SCIENCES, GÜLHANE SCHOOL OF MEDICINE, GÜLHANE MEDICINE PR. (ANKARA)
3 shared publications - Mine Filiz
Department of Infectious Diseases and Clinical Microbiology, Gülhane Research and Training Hospital, Health Science University, 06010 Ankara, Turkey
3 shared publications - Nesrin Öcal
Department of Pulmonary Medicine, University of Health Sciences Gulhane School of Medicine Ankara, Türkiye
3 shared publications
Latest Publications
- 23 July 2026
- Published by Taylor & Francis in AIDS Care
- p. 1-12
Beyond viral suppression: determinants of health-related quality of life in a national HIV cohort in Turkiye
This multicentre study evaluated Health-related Quality of Life (HRQoL) and identified sociodemographic and clinical determinants of physical and mental health outcomes in a large national HIV cohort in Turkiye. This cross-sectional study included 1303 adults across 23 centres. HRQoL was assessed using the Turkish MOS-HIV Health Survey, yielding Physical Health Summary (PHSS) and Mental Health Summary (MHSS) scores. HRQoL scores were dichotomised into "higher" (>50) and "lower" (≤50) groups. Data were analysed via univariate tests and multivariable logistic regression. Participants (88.6% male; median age: 38) were primarily single, employed, and university graduates. The median CD4+ T-cell count and HIV RNA level were 627 cells/mm3 and <50 copy/mL, respectively. Median PHSS and MHSS were 57.25 and 50.57, respectively. While social/role functioning scored highest, health transition scored lowest. Lower PHSS was identified in 22.7% of participants, whereas 47.9% reported lower MHSS. Low education and high daily pill burden significantly increased the risk of lower HRQoL. Interestingly, lower income was independently associated with better HRQoL, while older age and psychiatric treatment correlated with better MHSS. Despite robust physical HRQoL, mental health remains a significant challenge. To achieve "Fourth 90" targets, interventions should prioritise health literacy and integrated mental health services within HIV care.Abbreviations: ART: antiretroviral therapy; CF: cognitive functioning; CI: confidence interval; EF: energy/fatigue; GH: general health perception; HAART: highly active antiretroviral therapy; HD: health distress; HIV: human immunodeficiency virus; HL: Hosmer-Lemeshow; HRQoL: health-related quality of life; HT: health transition; MHS: mental health summary; MHSS: mental health summary score; MOS-HIV: medical outcomes study HIV health survey; OR: odds ratio; P: pain; PF: physical functioning; PHS: physical health summary; PHSS: physical health summary score; PLWH: people living with HIV; QL: quality of life; RF: role function; RNA: ribonucleic acid; SF: social function; UNAIDS: joint United Nations programme on HIV/AIDS.
- 23 July 2026
- Published by Taylor & Francis in AIDS Care
- p. 1-12
Beyond viral suppression: determinants of health-related quality of life in a national HIV cohort in Turkiye
This multicentre study evaluated Health-related Quality of Life (HRQoL) and identified sociodemographic and clinical determinants of physical and mental health outcomes in a large national HIV cohort in Turkiye. This cross-sectional study included 1303 adults across 23 centres. HRQoL was assessed using the Turkish MOS-HIV Health Survey, yielding Physical Health Summary (PHSS) and Mental Health Summary (MHSS) scores. HRQoL scores were dichotomised into "higher" (>50) and "lower" (≤50) groups. Data were analysed via univariate tests and multivariable logistic regression. Participants (88.6% male; median age: 38) were primarily single, employed, and university graduates. The median CD4+ T-cell count and HIV RNA level were 627 cells/mm3 and <50 copy/mL, respectively. Median PHSS and MHSS were 57.25 and 50.57, respectively. While social/role functioning scored highest, health transition scored lowest. Lower PHSS was identified in 22.7% of participants, whereas 47.9% reported lower MHSS. Low education and high daily pill burden significantly increased the risk of lower HRQoL. Interestingly, lower income was independently associated with better HRQoL, while older age and psychiatric treatment correlated with better MHSS. Despite robust physical HRQoL, mental health remains a significant challenge. To achieve "Fourth 90" targets, interventions should prioritise health literacy and integrated mental health services within HIV care.Abbreviations: ART: antiretroviral therapy; CF: cognitive functioning; CI: confidence interval; EF: energy/fatigue; GH: general health perception; HAART: highly active antiretroviral therapy; HD: health distress; HIV: human immunodeficiency virus; HL: Hosmer-Lemeshow; HRQoL: health-related quality of life; HT: health transition; MHS: mental health summary; MHSS: mental health summary score; MOS-HIV: medical outcomes study HIV health survey; OR: odds ratio; P: pain; PF: physical functioning; PHS: physical health summary; PHSS: physical health summary score; PLWH: people living with HIV; QL: quality of life; RF: role function; RNA: ribonucleic acid; SF: social function; UNAIDS: joint United Nations programme on HIV/AIDS.
- 1 January 2024
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (4)
Lupus Nefriti ile Karışan Visseral Leishmaniasis Olgusu
- 1 January 2024
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (4)
Lupus Nefriti ile Karışan Visseral Leishmaniasis Olgusu
- Open Access
- 26 August 2021
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 20 (2) , 81-86
COVID 19 hastalarında karaciğer fonksiyon bozukluğu ve prognoz ile ilişkisi
Giriş ve Amaç: COVID-19’da karaciğer hasarının ana mekanizmasının, şiddetli akut solunum sendromu koronavirüs-2'nin safra kanalı hücrelerinde yüksek oranda eksprese edilen anjiyotensin dönüştürücü enzim 2 reseptörüne bağlanması olduğu düşünülmektedir. Bu çalışmada COVID-19 tanısı ile yatırılarak takip ve tedavi edilen hastaların, komorbid karaciğer hastalıklarının araştırılması, yatış gününde anormal karaciğer biyokimyasal test sonuçları sıklığının değerlendirilerek hastalığın seyri ve prognozu ile ilişkisinin araştırılması amaçlandı. Gereç ve Yöntem: COVID-19 tanısı ile yatırılarak tedavi edilen 18 yaşından büyük hastalara ait veriler retrospektif olarak değerlendirildi. Hastaların aspartat aminotransferaz, alanin aminotransferaz, alkalen fosfataz, gama glutamil transferaz, total bilirübin değerleri ile hastanede kalış süreleri, yoğun bakım ünitesi ihtiyacı, mortalite arasındaki ilişki araştırıldı. Bulgular: COVID-19 tanısı revers transkripsiyon polimeraz zincir reaksiyonu ile doğrulanmış 795 hastadan 113’ünde (%14.2) yüksek karaciğer enzim (alanin aminotransferaz ve/veya aspartat aminotransferaz) prevalansı saptandı. COVID-19’lu olgularda yüksek alanin aminotransferaz prevalansı %11.1 iken aspartat aminotransferaz prevalansı ise %9.6 idi. Alanin aminotransferaz yüksekliği en fazla 71 yaş ve üstünde (%17.4), aspartat aminotransferaz yüksekliği ise en fazla 51-70 yaş grubunda (%14.8) bulundu. Alanin aminotransferaz ve/veya aspartat aminotransferaz yüksekliği saptanan ve saptanmayan hastalar arasında, hastalığın seyri, hastanede ve yoğun bakımda yatış süresi ve mortalite açısından anlamlı bir fark tespit edilmedi. Ayrıca, aspartat aminotransferaz ve alanin aminotransferaz yüksekliğinin sağ kalım zamanında anlamlı bir fark oluşturmadığı saptandı. Sonuç: COVID-19 hastalarında anormal karaciğer fonksiyon testleri tespit edilebilir. Ancak bunun sebepleri ve prognoza etkileri konusunda yeterli bilgiye sahip olmak için daha geniş popülasyonu içeren prospektif çalışmalara ihtiyaç vardır.
- 26 August 2021
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 20 (2) , 81-86
Open AccessCOVID 19 hastalarında karaciğer fonksiyon bozukluğu ve prognoz ile ilişkisi
Giriş ve Amaç: COVID-19’da karaciğer hasarının ana mekanizmasının, şiddetli akut solunum sendromu koronavirüs-2'nin safra kanalı hücrelerinde yüksek oranda eksprese edilen anjiyotensin dönüştürücü enzim 2 reseptörüne bağlanması olduğu düşünülmektedir. Bu çalışmada COVID-19 tanısı ile yatırılarak takip ve tedavi edilen hastaların, komorbid karaciğer hastalıklarının araştırılması, yatış gününde anormal karaciğer biyokimyasal test sonuçları sıklığının değerlendirilerek hastalığın seyri ve prognozu ile ilişkisinin araştırılması amaçlandı. Gereç ve Yöntem: COVID-19 tanısı ile yatırılarak tedavi edilen 18 yaşından büyük hastalara ait veriler retrospektif olarak değerlendirildi. Hastaların aspartat aminotransferaz, alanin aminotransferaz, alkalen fosfataz, gama glutamil transferaz, total bilirübin değerleri ile hastanede kalış süreleri, yoğun bakım ünitesi ihtiyacı, mortalite arasındaki ilişki araştırıldı. Bulgular: COVID-19 tanısı revers transkripsiyon polimeraz zincir reaksiyonu ile doğrulanmış 795 hastadan 113’ünde (%14.2) yüksek karaciğer enzim (alanin aminotransferaz ve/veya aspartat aminotransferaz) prevalansı saptandı. COVID-19’lu olgularda yüksek alanin aminotransferaz prevalansı %11.1 iken aspartat aminotransferaz prevalansı ise %9.6 idi. Alanin aminotransferaz yüksekliği en fazla 71 yaş ve üstünde (%17.4), aspartat aminotransferaz yüksekliği ise en fazla 51-70 yaş grubunda (%14.8) bulundu. Alanin aminotransferaz ve/veya aspartat aminotransferaz yüksekliği saptanan ve saptanmayan hastalar arasında, hastalığın seyri, hastanede ve yoğun bakımda yatış süresi ve mortalite açısından anlamlı bir fark tespit edilmedi. Ayrıca, aspartat aminotransferaz ve alanin aminotransferaz yüksekliğinin sağ kalım zamanında anlamlı bir fark oluşturmadığı saptandı. Sonuç: COVID-19 hastalarında anormal karaciğer fonksiyon testleri tespit edilebilir. Ancak bunun sebepleri ve prognoza etkileri konusunda yeterli bilgiye sahip olmak için daha geniş popülasyonu içeren prospektif çalışmalara ihtiyaç vardır.
- 14 June 2021
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 26 (2) , 257-266
COVID-19 Pandemisinde Üçüncü Basamak Bir Hastane Deneyimi
- 14 June 2021
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 26 (2) , 257-266
COVID-19 Pandemisinde Üçüncü Basamak Bir Hastane Deneyimi
- 9 June 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (9) , e14459
Relationship between chest computed tomography findings and clinical conditions of coronavirus disease (COVID‐19): A multicentre experience
Aims This study aimed to investigate the clinical and chest computed tomography (CT) features associated with clinical parameters for coronavirus disease (COVID-19) in the capital of Turkey, Ankara. Materials and methods Epidemiological, clinical features, laboratory findings and radiological characteristics of 1563 hospitalised patients with COVID-19 in Ankara were collected, reviewed and analysed in this study. The risk factors associated with disease severity were investigated. Results Non-severe (1214; 77.7%) and severe cases (349; 22.3%) were enrolled in the study. Compared with the non-severe group, the severe group were significantly older and had more comorbidities (ie, hypertension, diabetes mellitus, cardiovascular disease and chronic kidney disease). Smoking was more common in the severe group. Severe patients had higher respiratory rates and higher incidences of cough and dyspnoea compared with non-severe patients. Compared with the non-severe patients, the severe patients had increased C-reactive protein (CRP), procalcitonin, neutrophil to lymphocyte ratio (NLR) and CRP/albumin ratio and decreased albumin. The occurrence rates of consolidation, subpleural sparing, crazy-paving pattern, cavity, halo sign, reversed halo sign, air bronchogram, pleural thickening, micronodule, subpleural curvilinear line and multilobar and bilateral involvement in the CT finding of the severe patients were significantly higher than those of the non-severe patients. Conclusions Many factors are related to the severity of COVID-19, which can help clinicians judge the severity of the patient and evaluate the prognosis. This cohort study revealed that male sex, age (≥55 years), patients with any comorbidities, especially those with cardiovascular disease, dyspnoea, increased CRP, D-dimer and NLR, and decreased lymphocyte count and CT findings of consolidation and multilobar involvement were predictors of severe COVID-19.
- 9 June 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (9) , e14459
Relationship between chest computed tomography findings and clinical conditions of coronavirus disease (COVID‐19): A multicentre experience
Aims This study aimed to investigate the clinical and chest computed tomography (CT) features associated with clinical parameters for coronavirus disease (COVID-19) in the capital of Turkey, Ankara. Materials and methods Epidemiological, clinical features, laboratory findings and radiological characteristics of 1563 hospitalised patients with COVID-19 in Ankara were collected, reviewed and analysed in this study. The risk factors associated with disease severity were investigated. Results Non-severe (1214; 77.7%) and severe cases (349; 22.3%) were enrolled in the study. Compared with the non-severe group, the severe group were significantly older and had more comorbidities (ie, hypertension, diabetes mellitus, cardiovascular disease and chronic kidney disease). Smoking was more common in the severe group. Severe patients had higher respiratory rates and higher incidences of cough and dyspnoea compared with non-severe patients. Compared with the non-severe patients, the severe patients had increased C-reactive protein (CRP), procalcitonin, neutrophil to lymphocyte ratio (NLR) and CRP/albumin ratio and decreased albumin. The occurrence rates of consolidation, subpleural sparing, crazy-paving pattern, cavity, halo sign, reversed halo sign, air bronchogram, pleural thickening, micronodule, subpleural curvilinear line and multilobar and bilateral involvement in the CT finding of the severe patients were significantly higher than those of the non-severe patients. Conclusions Many factors are related to the severity of COVID-19, which can help clinicians judge the severity of the patient and evaluate the prognosis. This cohort study revealed that male sex, age (≥55 years), patients with any comorbidities, especially those with cardiovascular disease, dyspnoea, increased CRP, D-dimer and NLR, and decreased lymphocyte count and CT findings of consolidation and multilobar involvement were predictors of severe COVID-19.
- Open Access
- 9 June 2021
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (9) , e14461
The boundaries between survival and nonsurvival at COVID‐19: Experience of tertiary care pandemic hospital
Objective Coronavirus disease 2019 (COVID-19) is an emerging, fast-spreading, highly mortal and worldwide infectious disease. The pulmonary system was defined as the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mortality concept of this disease presented with more severe and systemic disease. The present study investigated the relationship between the patient characteristics at the initial hospital administration and fatality in COVID-19 patients. Methods In this retrospective and comparative cohort study, all the 767 hospitalised COVID-19 patients, treated between 18 March and 15 May 2020 in the Covid Clinics of Gulhane Training and Research Hospital in Ankara, Turkey, were evaluated. Results The fatality rate was significantly increased in patients with any comorbid disease except asthma. The initial laboratory test results indicated highly significant differences according to the patient's outcome. A multifactor logistic regression analysis was performed to calculate the adjusted odds ratios for predicting patient outcomes. Being older than 60 years increased the death risk with an adjusted OR of 7.2 (95% CI: 2.23-23.51; P = .001). The presence of a cancer and the extended duration of intensive care unit treatment were other significant risk factors for nonsurvival. Azithromycin treatment was determined as significantly reduced the death ratio in these patients (P = .002). Conclusion It was revealed that being older than 60 years, presence of a cancer and extended duration of ICU treatment were the major risk factors for predicting fatality rate in hospitalised COVID-19 patients.
- 9 June 2021
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (9) , e14461
Open AccessThe boundaries between survival and nonsurvival at COVID‐19: Experience of tertiary care pandemic hospital
Objective Coronavirus disease 2019 (COVID-19) is an emerging, fast-spreading, highly mortal and worldwide infectious disease. The pulmonary system was defined as the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mortality concept of this disease presented with more severe and systemic disease. The present study investigated the relationship between the patient characteristics at the initial hospital administration and fatality in COVID-19 patients. Methods In this retrospective and comparative cohort study, all the 767 hospitalised COVID-19 patients, treated between 18 March and 15 May 2020 in the Covid Clinics of Gulhane Training and Research Hospital in Ankara, Turkey, were evaluated. Results The fatality rate was significantly increased in patients with any comorbid disease except asthma. The initial laboratory test results indicated highly significant differences according to the patient's outcome. A multifactor logistic regression analysis was performed to calculate the adjusted odds ratios for predicting patient outcomes. Being older than 60 years increased the death risk with an adjusted OR of 7.2 (95% CI: 2.23-23.51; P = .001). The presence of a cancer and the extended duration of intensive care unit treatment were other significant risk factors for nonsurvival. Azithromycin treatment was determined as significantly reduced the death ratio in these patients (P = .002). Conclusion It was revealed that being older than 60 years, presence of a cancer and extended duration of ICU treatment were the major risk factors for predicting fatality rate in hospitalised COVID-19 patients.
- Open Access
- 1 January 2019
- Published by Turkiye Klinikleri in Turkiye Klinikleri Journal of Medical Sciences
- Vol. 39 (3) , 251-257
Evaluation of Risk Factors for Candida Colonization and Infection in Non-Neutropenic Intensive Care Patients
Objective: In patients who are followed in intensive care unit (ICU), colonization and/or invasive infections with Candida species occur in the presence of various risk factors. Difficulties in diagnosis cause delays in antifungal therapy and this is related with increased mortality. Material and Methods: In this retrospective case control study, patients were classified as colonized, infected and control group and independent risk factors for candida colonization and invasive candida infections were evaluated. Patients followed in anesthesiology-reanimation and medical ICU's of Ankara University Ibn-i Sina Hospital between June 2013 and June 2015, were retrospectively screened. A total of 225 patients, who stayed more than 48 hours in ICU, who are non-neutropenic and on the age above 18, were included. All demographics and risk factors were recorded. Results: Central venous catheter and sepsis/septic shock were found independent risk factors for candida colonisation (P=0.011, P=0.018); presence of central venous catheter, TPN use and sepsis/septic shock were found independent risk factors for candida infection (P=0.037, P<0.001, P=0.040). Conclusion: In high risk patients, early and appropriate antifungal therapy decreases mortality. Therefore, for doctors, who works with intensive care, identifying high risk patients for invasive candida infections is important. Presence of central venous catheter, sepsis/septic shock and TPN use should be considered in intensive care patients.Amaç: Yoğun bakım ünitesinde takip edilen hastalarda çeşitli risk faktörlerinin varlığında kandida türleri ile kolonizasyon ve enfeksiyon gelişebilmektedir. Tanıdaki gecikme antifungal tedavinin de gecikmesine yol açmakta ve bu durum mortalitede artışla sonuçlanmaktadır. Gereç ve Yöntemler: Çalışma retrospektif vaka kontrol çalışması şeklinde yapılmış olup hastalar kolonize enfekte ve kontrol grubu olarak ayrılmış kandida kolonizasyonu ve invazif kandida enfeksiyon gelişimi için bağımsız risk faktörleri değerlendirilmiştir. Ankara Üniversitesi İbn-i Sina Hastanesi anesteziyoloji-reanimasyon ve dahili yoğun bakım ünitelerinde 2013-2015 yılları arasında takip edilen hastalar retrospektif olarak taranmıştır. Yoğun bakım ünitesinde en az 48 saat yatışı olan, nötropenik olmayan 18 yaş üstü toplam 225 hasta çalışmaya dahil edilmiştir. Hastalara ait demografik bilgiler ve risk faktörleri kaydedilmiştir. Bulgular: Santral venöz kateter kullanımı ve sepsis/septik şok kandida kolonizasyonu için (p=0,011, p=0,018), santral venöz kateter kullanımı, TPN kullanımı ve sepsis/septik şok ise invaziv kandida enfeksiyonu için bağımsız risk faktörleri olarak bulundu (P=0,037, P<0,001, P=0,040). Sonuç: Yüksek riskli hastalarda, erken ve uygun antifungal tedavi mortaliteyi azaltmaktadır. Bu nedenle yoğun bakım hastaları ile çalışan hekimler için invazif kandida enfeksiyonları için yüksek riskli hastaları belirlemek önemlidir. Santral venöz kateter varlığı, sepsis/septik şok ve TPN kullanımı yoğun bakım hastalarında göz önünde bulundurulmalıdır.
- 1 January 2019
- Published by Turkiye Klinikleri in Turkiye Klinikleri Journal of Medical Sciences
- Vol. 39 (3) , 251-257
Open AccessEvaluation of Risk Factors for Candida Colonization and Infection in Non-Neutropenic Intensive Care Patients
Objective: In patients who are followed in intensive care unit (ICU), colonization and/or invasive infections with Candida species occur in the presence of various risk factors. Difficulties in diagnosis cause delays in antifungal therapy and this is related with increased mortality. Material and Methods: In this retrospective case control study, patients were classified as colonized, infected and control group and independent risk factors for candida colonization and invasive candida infections were evaluated. Patients followed in anesthesiology-reanimation and medical ICU's of Ankara University Ibn-i Sina Hospital between June 2013 and June 2015, were retrospectively screened. A total of 225 patients, who stayed more than 48 hours in ICU, who are non-neutropenic and on the age above 18, were included. All demographics and risk factors were recorded. Results: Central venous catheter and sepsis/septic shock were found independent risk factors for candida colonisation (P=0.011, P=0.018); presence of central venous catheter, TPN use and sepsis/septic shock were found independent risk factors for candida infection (P=0.037, P<0.001, P=0.040). Conclusion: In high risk patients, early and appropriate antifungal therapy decreases mortality. Therefore, for doctors, who works with intensive care, identifying high risk patients for invasive candida infections is important. Presence of central venous catheter, sepsis/septic shock and TPN use should be considered in intensive care patients.Amaç: Yoğun bakım ünitesinde takip edilen hastalarda çeşitli risk faktörlerinin varlığında kandida türleri ile kolonizasyon ve enfeksiyon gelişebilmektedir. Tanıdaki gecikme antifungal tedavinin de gecikmesine yol açmakta ve bu durum mortalitede artışla sonuçlanmaktadır. Gereç ve Yöntemler: Çalışma retrospektif vaka kontrol çalışması şeklinde yapılmış olup hastalar kolonize enfekte ve kontrol grubu olarak ayrılmış kandida kolonizasyonu ve invazif kandida enfeksiyon gelişimi için bağımsız risk faktörleri değerlendirilmiştir. Ankara Üniversitesi İbn-i Sina Hastanesi anesteziyoloji-reanimasyon ve dahili yoğun bakım ünitelerinde 2013-2015 yılları arasında takip edilen hastalar retrospektif olarak taranmıştır. Yoğun bakım ünitesinde en az 48 saat yatışı olan, nötropenik olmayan 18 yaş üstü toplam 225 hasta çalışmaya dahil edilmiştir. Hastalara ait demografik bilgiler ve risk faktörleri kaydedilmiştir. Bulgular: Santral venöz kateter kullanımı ve sepsis/septik şok kandida kolonizasyonu için (p=0,011, p=0,018), santral venöz kateter kullanımı, TPN kullanımı ve sepsis/septik şok ise invaziv kandida enfeksiyonu için bağımsız risk faktörleri olarak bulundu (P=0,037, P<0,001, P=0,040). Sonuç: Yüksek riskli hastalarda, erken ve uygun antifungal tedavi mortaliteyi azaltmaktadır. Bu nedenle yoğun bakım hastaları ile çalışan hekimler için invazif kandida enfeksiyonları için yüksek riskli hastaları belirlemek önemlidir. Santral venöz kateter varlığı, sepsis/septik şok ve TPN kullanımı yoğun bakım hastalarında göz önünde bulundurulmalıdır.